18 studies found for:    acc-001
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: ACC-001 (vanutide cridificar)
2 Completed Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: ACC-001 3 μg/ QS-21 50 μg;   Biological: ACC-001 10 μg/ QS-21 50 μg;   Other: Placebo- Phosphate buffered saline (PBS)
3 Completed Study Evaluating Safety, Tolerability, And Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001 + QS-21;   Biological: ACC-001;   Biological: QS-21;   Drug: Placebo: Phosphate buffered saline
4 Completed Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001 + QS-21;   Biological: QS-21;   Other: Diluent: Phosphate Buffered Saline;   Biological: ACC-001
5 Completed Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: ACC-001;   Other: QS-21;   Other: PBS
6 Completed Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: ACC-001+ QS21;   Drug: ACC-001;   Drug: ACC-001 + QS21
7 Terminated Long Term Extension Study Evaluating Safety, Tolerability And Immunogenicity Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: ACC-001
8 Completed A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: ACC-001+ QS21
9 Completed Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: ACC-001;   Other: QS-21
10 Completed Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
Condition: Dietary Carcinogenesis
Interventions: Drug: ACCS100;   Drug: Placebo
11 Recruiting A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Conditions: Cancer;   Neuroendocrine Tumors;   NET;   Adrenocortical Carcinoma;   ACC
Intervention: Drug: TKM-080301
12 Completed
Has Results
Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2
Interventions: Device: BD/33G;   Device: OTM / 33G;   Device: OTU/28G;   Device: ACC/28G;   Device: OTM/28G
13 Recruiting Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Conditions: Adrenocortical Carcinoma;   Adrenal Cancer;   ACC
Intervention: Drug: ATR-101
14 Completed Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
Condition: Uveitis, Anterior
Interventions: Drug: EGP-437 1.6 mA-min at 0.4 with EyeGate® II System;   Drug: EGP-437 4.8 mA-min at 1.2 mA with EyeGate® II System;   Drug: EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System;   Drug: EGP-437 14.0 mA-min at 3.5 mA with EyeGate® II System
15 Completed Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Condition: Carcinoma, Adrenal Cortical
Interventions: Drug: Etoposide;   Drug: Doxorubicin;   Drug: Cisplatin;   Drug: Streptozotocin;   Drug: Mitotane
16 Unknown  Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
Condition: HIV Infections
Interventions: Drug: lamivudine, abacavir , ritonavir, atazanavir;   Drug: emtricitabine, tenofovir, ritonavir, atazanavir
17 Terminated CyberKnife® for Hepatic Metastases From Colorectal Cancer
Condition: Colorectal Liver Metastases
Intervention: Radiation: CyberKnife SBRT
18 Completed Growth and Safety of a Low Lactose Milk-Based Infant Formula
Conditions: Growth;   Healthy Term Infants
Intervention: Other: Low Lactose Infant Formula

Indicates status has not been verified in more than two years